Remote Participation (Within USA) Trial of Sana Pain Reliever
CompletedNot applicableNCT04280562
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Randomized controlled trial to assess the effectiveness and patient perception of the benefit of the Sana Pain Reliever in individuals with chronic neuropathic pain.The study is fully remote with four study visits taking place over teleconferencing and the study devices mailed to the participants to use at home for 8-14 weeks.
Study details
- Official title
- Extended Home-use Trial of a Novel Device to Reduce Chronic Neuropathic Pain
- Conditions
- Interventions
- Device: Sana Pain Reliever
- Device: Sham SPR
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Collaborators
- Sana Health, Inc.
- Start date
- 2020-01-31
- Primary completion
- 2023-02-21
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Confirmed clinical diagnosis of neuropathic pain * Age of 18 years or older at time of consent * Fluent in English * Consistent medications for the last 4 weeks prior to the first baseline visit (week 0) Exclusion Criteria: * Diagnosis of photosensitive epilepsy * Active ear or eye infection * Vision impairments that affect perception of light in one or both eyes * Deafness in one or both ears * Severe depression (Score higher than 30 points on the Beck's Depression Inventory)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04280562